Results 51 to 60 of about 7,941 (258)
Vaccine development against Leishmania donovani
Frontiers in Immunology, 2012 Visceral leishmaniasis (VL) caused by Leishmania donovani and Leishmania infantum/ chagasi represents the second most challenging infectious disease worldwide, affecting nearly 500,000 people and 60,000 deaths annually.
Amrita eDas, NAHID eALI
doaj +1 more source
Immunoprophylaxis in asplenic patients
International Journal of Surgery, 2009 The asplenic patient is at risk of overwhelming post-splenectomy infection (OPSI) due to encapsulated bacteria, namely pneumococcus, haemophilus influenza B and meningococcal C pathogens. The lifetime risk is 1-2% with the estimated mortality being in the region of 40-70% (Davidson RN, Wall RA.
Harji, D.P. +3 more
openaire +2 more sources
Vaccines, 2015 Vaccination has proven to be an invaluable means of preventing infectious diseases by reducing both incidence of disease and mortality. However, vaccines have not been effectively developed for many diseases including HIV-1, hepatitis C virus (HCV ...
Rebecca J. Loomis, Philip R. Johnson
doaj +1 more source
Immunoglobulin concentration in blood serum of postcolostral calves: Ratio between immunoglobulin level and appearance of enzootic pneumonia [PDF]
Veterinarski Glasnik, 2007 The timely supply of newborn calves with optimal quantities of colostrum has a key role in the process of immune protection in the early phase of their lives.
Jonić Branko
doaj +1 more source
eJHaem, Volume 7, Issue 3, June 2026.ABSTRACT Introduction Safe outpatient delivery of B‐cell maturation antigen–targeting bispecific antibodies (BCMA‐BsAbs) in multiple myeloma (MM) is challenging, particularly during step‐up dosing (SUD). Standardized guidance for European community practice is limited.
María‐Victoria Mateos +10 more
wiley +1 more source
Maternal and infant characteristics according to immunoprophylaxis failure.
, 2019 Maternal and infant characteristics according to immunoprophylaxis failure.
Phimpha Paboriboune (404248) +13 more
core +1 more source
IgY antibodies for the immunoprophylaxis and therapy of respiratory infections
Human Vaccines & Immunotherapeutics, 2018 Emergence of drug resistance among the causative organisms for respiratory tract infections represents a critical challenge to the global health care community.
A. Abbas +3 more
semanticscholar +1 more source
Improving disease prevention and treatment in controlled fish culture
Archives of Polish Fisheries, 2016 The aim of the work was to evaluate long-term results of studies focusing on improving methods for preventing and treating fish diseases using selected natural and syntetic immunomodulators and vaccines in fish culture. Simultaneously, attention is drawn
Terech-Majewska Elżbieta
doaj +1 more source
Frontiers in Immunology, 2021 The development and application of safe and effective immunoprophylactic/immunotherapeutic agents against canine visceral leishmaniasis (CanL) have been pointed out as the only means for the real control of the disease. Thus, this study aimed to evaluate
Rômulo Pessoa-e-Silva +8 more
doaj +1 more source
Immunoprophylaxis of Viral Hepatitis
Gastroenterology, 1979 The concept of immunotherapy and immunoprophylaxis for infectious diseases was introduced to clinical medicine in 1890, when von Behring and Kitasato reported that they had developed an antitoxin against diphtheria." The work they performed was so highly regarded that von Behring was selected to receive the Nobel Prize for Physiology and Medicine in ...
L B, Seeff, J H, Hoofnagle
openaire +2 more sources